Vickie S. Reed - 24 May 2022 Form 3 Insider Report for Adamis Pharmaceuticals Corp

Role
Director
Signature
/s/ David C. Benedicto, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
24 May 2022
Net transactions value
$0
Form type
3
Filing time
26 May 2022, 16:28:33 UTC
Previous filing
28 Apr 2022
Next filing
11 May 2023

No securities are beneficially owned.